Overview

Tolerability and Efficacy of L-Serine in Patients With Amyotrophic Lateral Sclerosis (ALS)

Status:
Recruiting
Trial end date:
2022-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the tolerability of L-Serine oral doses for ALS patients and assess preliminary indications of efficacy
Phase:
Phase 2
Details
Lead Sponsor:
Elijah W. Stommel
Collaborator:
Brain Chemistry Labs, Institute for Ethnomedicine